Sign in
CompletedPhase 4

Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
90 people enrolled
Started
13 Sept 2025
Ended
25 Mar 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • NaCl 0.9%
  • Dexamethasone 4mg
Record updated
22 May 2026

Who can take part

Age
65 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • patients scheduled for total knee arthroplasty
  • patients aged >65 and <100 years
  • patients can provide informed consent
  • patients can reliably report symptoms to the research team

Who cannot take part

  • inability to provide first-party consent due to cognitive impairment or a
  • infection at the site of the regional block,
  • coagulation disorders,
  • history of regular steroid medication
  • language barrier
  • immunodeficiency,
  • American Society of Anesthesiologists (ASA) physical status of IV or higher,

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

"The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in iPACK With ACB for Total Knee Arthroplasty" - written in plain language according to ClinicalTrials.gov standards:

Read full original descriptionShow less

The goal of this clinical trial is to learn how the route of dexamethasone administration (either through the vein or nerve block) affects pain and inflammation in people having total knee replacement surgery. All participants will receive two types of nerve blocks before surgery: an iPACK block and an adductor canal block (ACB), which help control pain after the operation.

The main questions the study aims to answer are:

Does injecting dexamethasone into the nerve block reduce pain more effectively than giving it by vein? Which method leads to a lower inflammatory response after surgery? Researchers will compare the two groups to see which route offers better pain relief and less swelling after knee surgery.

Participants will:

Be randomly assigned to receive dexamethasone either in the nerve block or by IV Receive standard care for total knee replacement Rate their pain and have blood tests after surgery to measure inflammation

The 3 groups in the trial

  • ControlPlacebo, for comparison

    iPACK block with ACB

    Treatment: NaCl 0.9%

  • iv DEXExisting treatment, for comparison

    iPACK block with ACB + iv Dexamethasone

    Treatment: Dexamethasone 4mg

  • pn DEXExisting treatment, for comparison

    iPACK block with ACB + perineural Dexamethasone

    Treatment: Dexamethasone 4mg

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Route of Dexamethasone Administration in iPACK and ACB for Total Knee Replacement: A Randomized Trial
Record updated
22 May 2026